Acer Medical Inc. (TPEX:6857)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
118.00
-3.00 (-2.48%)
Jun 6, 2025, 10:33 AM CST

Acer Medical Statistics

Total Valuation

Acer Medical has a market cap or net worth of TWD 1.80 billion. The enterprise value is 1.59 billion.

Market Cap 1.80B
Enterprise Value 1.59B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025.

Earnings Date Jul 31, 2025
Ex-Dividend Date n/a

Share Statistics

Acer Medical has 15.23 million shares outstanding.

Current Share Class 15.23M
Shares Outstanding 15.23M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 4.78%
Owned by Institutions (%) 0.48%
Float 3.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 35.82
PB Ratio 9.23
P/TBV Ratio 9.42
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -58.25
EV / Sales 31.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.84

Current Ratio 6.84
Quick Ratio 6.66
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -13.14% and return on invested capital (ROIC) is -9.06%.

Return on Equity (ROE) -13.14%
Return on Assets (ROA) -7.76%
Return on Invested Capital (ROIC) -9.06%
Return on Capital Employed (ROCE) -15.52%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 22
Asset Turnover 0.21
Inventory Turnover 2.33

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -35.87% in the last 52 weeks. The beta is 1.23, so Acer Medical's price volatility has been higher than the market average.

Beta (5Y) 1.23
52-Week Price Change -35.87%
50-Day Moving Average 125.85
200-Day Moving Average 142.36
Relative Strength Index (RSI) 40.38
Average Volume (20 Days) 2,188

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Acer Medical had revenue of TWD 50.16 million and -27.36 million in losses. Loss per share was -1.80.

Revenue 50.16M
Gross Profit 31.67M
Operating Income -30.20M
Pretax Income -27.36M
Net Income -27.36M
EBITDA -29.63M
EBIT -30.20M
Loss Per Share -1.80
Full Income Statement

Balance Sheet

The company has 202.78 million in cash and n/a in debt, giving a net cash position of 202.78 million or 13.32 per share.

Cash & Cash Equivalents 202.78M
Total Debt n/a
Net Cash 202.78M
Net Cash Per Share 13.32
Equity (Book Value) 194.59M
Book Value Per Share 12.78
Working Capital 188.59M
Full Balance Sheet

Cash Flow

Operating Cash Flow -20.70M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 63.15%, with operating and profit margins of -60.20% and -54.56%.

Gross Margin 63.15%
Operating Margin -60.20%
Pretax Margin -54.56%
Profit Margin -54.56%
EBITDA Margin -59.06%
EBIT Margin -60.20%
FCF Margin n/a

Dividends & Yields

Acer Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -1.52%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Acer Medical has an Altman Z-Score of 47.35.

Altman Z-Score 47.35
Piotroski F-Score n/a